HETEROCYCLES
An International Journal for Reviews and Communications in Heterocyclic ChemistryWeb Edition ISSN: 1881-0942
Published online by The Japan Institute of Heterocyclic Chemistry
e-Journal
Full Text HTML
Received, 17th October, 2008, Accepted, 18th December, 2008, Published online, 19th December, 2008.
DOI: 10.3987/COM-08-S(D)72
■ Artopeden A, a New Antiplasmodial Isoprenylated Flavone from Artocarpus champeden
Tutik Sri Wahyuni, Wiwied Ekasari, Aty Widyawaruyanti, Yusuke Hirasawa, Hiroshi Morita,* and Noor Cholies Zaini*
Faculty of Pharmaceutical Sciences, Hoshi University, 2-4-41 Ebara, Shinagawa-ku, Tokyo 142-8501, Japan
Abstract
A new isoprenylated flavone, artopeden A (1) was isolated from the barks of Artocarpus champeden (Moraceae), and the structure was elucidated by NMR spectral analysis. Artopeden A (1) showed a potent antiplasmodial activity with an IC50 of 0.045 μg/mL against Plasmodium falciparum 3D7.INTRODUCTION
Malaria, which is caused by parasites of the genus Plasmodium, is a most serious infections in many tropical and subtropical regions.1 Since the number of patients continues to rise mainly due to the emergence of widespread chloroquine-resistant and multiple-drug-resistant strains of malaria parasites, the discovery of new antimalarial drugs is urgently needed.2
Artocarpus champeden Spreng., belonging to the family Moraceae, is widely distributed throughout the tropical and subtropical regions of Southeast Asia. In Indonesia, this plant is commonly known as ‘‘Cempedak’’ and is traditionally used for treatment of fever, diarrhoea, and malaria.3 Several isoprenyl flavonoids with cytotoxicity,4 antimalarial activity,5 and interaction with IgE and IgM,6 have been isolated from A. champeden.7
As a part of our collaborative study, recent investigation of extracts from Cassia siamea,8 Peganum harmala,9 and Chisocheton ceramicus10 resulted in the isolation of some new alkaloids and limonoids with antiplasmodial activity. In this paper, we report the isolation and structure elucidation of a new isoprenylated flavone, artopeden A (1) with an antiplasmodial activity from the barks of Artocarpus champeden.
†Dedicated to Dr. John Daly, National Institutes of Health scientist emeritus.
RESULTS AND DISCUSSION
The dried stem bark of A. champeden was extracted successively with hexane, CH2Cl2, and MeOH. CH2Cl2-soluble materials were subjected to a vacuum silica gel column (CHCl3-EtOAc-MeOH mixture as gradient mobile phase. Fractionation was continued by an open silica gel column chromatography with CHCl3-EtOAc-MeOH mixture as gradient mobile phase. The active fraction was purified by preparative thin layer chromatography (CH3CN-MeOH-H2O, 4:1:1 as mobile phase) followed by preparative thin layer chromatography (CHCl3-MeOH, 19:1 as mobile phase) and an ODS column (MeOH/H2O 7:3 → 1:0) to afford artopeden A (1, 0.000016%) together with artoindonesianin S (2, 0.00004%),11 artoindonesianin E (12.0 mg: 0.00048%),5b artonin A (12.0 mg: 0.00048%),12 and cycloheterophyllin (19.3 mg: 0.00077%).13 MeOH-soluble materials were subjected to a silica gel column (CHCl3– MeOH mixtures as mobile phase), followed by an ODS column (MeOH/H2O 3:2 → 4:1) to give morachalcone A14 (3, 0.00002%).
Artopeden A (1, [α]D 0) showed the pseudomolecular ion peak at m/z 397 (M+H)+ in ESIMS, and the molecular formula, C22H20O7, was established by HRTOFMS [m/z 397.1268, (M+H)+ Δ -1.9 mDa]. IR spectrum suggested the presence of OH (3450 cm-1) and conjugated carbonyl (1640 cm-1) groups. The 13C NMR (Table 1) spectrum of 1 disclosed twenty-two carbon signals due to one conjugated carbonyl (δC 179.7), eleven sp2 quaternary carbons (δC 104.4, 104.5, 112.0, 133.4, 135.3, 148.3, 150.6, 156.2, 160.2, 161.3, and 164.6), one sp3 quaternary carbon (δC 93.7), three sp2 methines (δC 93.1, 98.8, and 102.8), one sp3 methine (δC 47.2), one sp3 methylene (δC 20.4), two methyls (δC 22.8 and 28.3), and two methoxy groups (δC 56.3 and 56.6). 1H and 13C signals for 1 were assigned by detailed analysis of the 2D NMR spectra.
The 1H NMR spectrum of 1 showed the signals for the following protons: three aromatic protons [δH 6.33 (1H, d, 2.2), 6.72 (1H, d, 2.2), and 6.45 (1H, s)], two methyl protons [δH 1.36 (3H, s) and 1.68 (3H, s)], ABX type protons [δH 2.40 (1H, dd, 15.2, 15.2), 3.24 (1H, dd, 15.2, 7.1), and 3.44 (1H, dd, 15.2, 7.1)], and two methoxy protons [δH 3.89 (3H, s) and 3.92 (3H, s)]. The chemical shifts and coupling patterns of 1 were similar to those of artonin L,15 which has already been isolated from Artocarpus heterophyllus.13 The chemical shifts of all the carbons were similar to those of the relevant carbons of artonin L with the exception of the shifts of the four carbons (C-2’, 3’, 4’, and 5’) (Table 1). In the case of artonin L, the presence of methoxy group at C-2’ caused higher field shift (Δ +0.15 ppm) of the proton at the C-8 position when compared to that of hydroxy group (artonin L: 6.51 ppm at C-8; artopeden A: 6.72 ppm at C-8).15 Thus, the gross structure of artopeden A was assigned as 1 with a methoxy group at C-4’, which was an isomer of artonin L. Since artopeden A (1) did not show the optical rotation, 1 might be biogenetically derived from artoindonesianin S (2) through the oxidative coupling, which was the same case as in artonins A and B.12
Malaria is the most prevalent parasitic disease. According to World Health Organization (WHO), as many as 300–500 million people suffer from malaria. Artocarpus champeden has been traditionally used for treatment of malaria,3 and some isoprenylated flavonoids and stilbenes from Artocarpus species have already been reported on inhibitory activity against some parasites.5 Artopeden A (1) showed a potent in vitro antiplasmodial activity against Plasmodium falciparum 3D7 (artopeden A: IC50 0.045 μg/ml; chloroqine: IC50 0.0061 μg/mL).
EXPERIMENTAL
General Experimental Procedures. 1H and 2D NMR spectra were recorded on a Bruker AV 400 spectrometer and chemical shifts were reported using residual acetone-d6 (δH 2.06 and δC 29.8) as internal standards. Standard pulse sequences were employed for the 2D NMR experiments. Mass spectra were obtained with a Micromass LCT spectrometer.
Plant Material. Dried stem bark of A. champeden was collected from ‘‘Mak Balim’’ village, Sorong, Irian Jaya, Indonesia, in August 2004. A voucher specimen was identified by Dr. Eko Baroto Walujo at the Herbarium Bogoriense, LIPI - Research center For Biology, Bogor, Indonesia, and it was deposited at the herbarium of Bogor Botanical Garden.
Extraction and Isolation. Dried powder of A. champeden stem bark (2.5 kg) was macerated successively in hexane, CH2Cl2, and MeOH. The CH2Cl2 extract (32.0 g) was fractionated by a vacuum silica gel column chromatography with CHCl3–EtOAc-MeOH mixtures as mobile phases. Fractionation was continued by an open silica gel column chromatography with CHCl3-EtOAc-MeOH mixture as gradient mobile phase. The active fraction was purified by preparative thin layer chromatography (CH3CN-MeOH-H2O, 4:1:1 as mobile phase) followed by preparative thin layer chromatography (CHCl3-MeOH, 19:1 as mobile phase) and an ODS column (MeOH/H2O 7:3 → 1:0) to afford artopeden A (1, 0.4 mg: 0.000016%) together with artoindonesianin S (2, 1.0 mg: 0.00004%), artoindonesianin E (12.0 mg: 0.00048%),5b artonin A (12.0 mg: 0.00048%),12 and cycloheterophyllin (19.3 mg: 0.00077%).13 The MeOH fraction was further chromatographed on silica gel column chromatography, with CHCl3–MeOH mixtures as mobile phases, followed by repeated purification by reversed-phase column chromatography with MeOH-H2O mixture as mobile phases to yield morachalcone A14 (3, 0.5 mg: 0.00002%).
Artopeden A (1): yellow powder; [α]D23 0 (c 1.0, MeOH ); IR (KBr) νmax 3450, 2940, and 1640 cm-1; UV (MeOH) λmax 370 (log ε 4.3) and 205 (log ε 4.3) nm; 1H and 13C NMR data (Table 1); ESIMS m/z 397 (M+H)+; HRTOFMS m/z 397.1268 [(M+H)+, calcd for C22H21O7, 397.1287].
Antiplasmodial Assay. Human malaria parasites were cultured according to the method by W. Trager et al.16 The antimalarial activity of the isolated compounds was determined by the procedure described by Budimulja et al.17 In brief, Stock solution of the samples were prepared in DMSO (final DMSO concentrations of < 0.5%) and were diluted to the required concentration with complete medium (RPMI 1640 supplemented with 10% human plasma, 25 mM HEPES and 25 mM NaHCO3 ) until the final concentration of samples at well culture plate were : 10; 1; 0.1; 0.01; 0.001 μg/mL. The malarial parasite P. falciparum 3D7 clone was propagated in a 24-well culture plate in the presence of a wide range of concentrations of each compound. The growth of the par¬asite was monitored by making a blood smear fixed with MeOH and stained with Geimsa solution. The antimalarial activity of each compound was expressed as an IC50 value, defined as the concentration of the compound causing 50% inhibition of parasite growth relative to an untreated con¬trol.
The percentage of growth inhibition was expressed according to following equation : Growth inhibition % = 100 - [(test parasitaemia/control parasitemia) × 100. Chloroqine: IC50= 0.0061 μg/mL.
ACKNOWLEDGMENTS
We acknowledge the financial support provided by Assessment Service Unit, Faculty of Pharmacy, Airlangga University. This work was also supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, and The Open Research Center Project.
References
1. J. Wiesner, R. Ortmann, H. Jomaa, and M. Schlitzer, Angew. Chem. Int. Ed., 2003, 42, 5274. CrossRef
2. (a) M. H. Gelb and W. G. Hol, Science, 2002, 297, 343; CrossRef (b) P. A. G. N. De Smet, Drugs, 1997, 54, 801. CrossRef
3. S. A. Achmad, Bull. Soc. Nat. Prod. Chem. (Indonesia), 2004, 4, 35.
4. E. H. Hakim, A. Fahriyati, M. S. Kau, S. A. Achmad, L. Makmur, E. L. Ghisalberti, and T. Nomura, J. Nat. Prod., 1999, 62, 613. CrossRef
5. (a) C. Boonlaksiri, W. Oonant, P. Kongsaeree, P. Kittakoop, M. Tanticharoen, and Y. Thebtharanonth, Phytochemistry, 2000, 54, 415; CrossRef (b) A. Widyawaruyanti, Subehan, S. K. Kalauni, S. Awale, M. Nindatu, N. C. Zaini, D. Syafruddin, P. B. S. Asih, Y. Tezuka, and S. Kadota, J. Nat. Med., 2007, 61, 410. CrossRef
6. S. A. Achmad, E. H. Hakim, L. D. Juliawaty, L. Makmur, Suyatno, N. Aimi, and E. L. Ghisalberti, J. Nat .Prod., 1996, 59, 878. CrossRef
7. Y. M. Syah, L. D. Juliawaty, S. A. Achmad, E. H. Hakim, and E. L. Ghisalberti, J. Nat. Med., 2007, 60, 308. CrossRef
8. (a) H. Morita, S. Oshimi, Y. Hirasawa, K. Koyama, T. Honda, W. Ekasari, G. Indrayanto, and N. C. Zaini, Org. Lett., 2007, 9, 3691; CrossRef (b) S. Oshimi, Y. Tomizawa, Y. Hirasawa, T. Honda, W. Ekasari, A. Widyawaruyanti, M. Rudyanto, G. Indrayanto, N. C. Zaini, and H. Morita, Bioorg. Med. Chem. Lett., 2008, 18, 3761. CrossRef
9. A. Astulla, K. Zaima, Y. Matsuno, Y. Hirasawa, W. Ekasari, A. Widyawaruyanti, N. C. Zaini, and H. Morita, J. Nat. Med., 2008, 62, 470. CrossRef
10. K. Mohamad, Y. Hirasawa, M. Litaudon, K. Awang, A. H. A. Hadi, K. Takeya, W. Ekasari, A. Widyawaruyanti, N. C. Zaini, and H. Morita, Bioorg. Med. Chem., in press.
11. Y. M. Syah, S. A. Achmad, E. L. Ghisalberti, E. H. Hakim, L. Makmur, and D. Mujahidin, Phytochemistry, 2002, 61, 949. CrossRef
12. Y. Hano, M. Aida, M. Shiina, T. Nomura, T. Kawai, H. Ohe, and K. Kagei, Heterocycles, 1989, 29, 1447. CrossRef
13. B. L. Wei, J. R. Weng, P. H. Chiu, C. F. Hung, J. P. Wang, and C. N. Lin, J. Agric. Food Chem., 2005, 53, 3867. CrossRef
14. Y. Hano, S. Suzuki, T. Nomura, and S. Ueda, Heterocycles, 1989, 29, 807. CrossRef
15. M. Aida, K. Shinomiya, Y. Hano, and T. Nomura, Heterocycles, 1993, 36, 575. CrossRef
16. W. Trager and J. B. Jensen, Science, 1976, 193, 673. CrossRef
17. A. S. Budimulja, Syafruddin, P. Tapchaisri, P. Wilairat, and S. Marzuki, Mol. Biochem. Parasitol., 1997, 84, 137. CrossRef